# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001193125-20-139879
Filing Date
2020-05-12
Accepted
2020-05-12 10:50:38
Documents
4
Period of Report
2020-05-12
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | d876521d8k.htm | 8-K | 18064
2 | EX-99.1 | d876521dex991.htm | EX-99.1 | 14716
3 | EX-99.2 | d876521dex992.htm | EX-99.2 | 22258
4 | GRAPHIC | g876521ex99p1g1.jpg | GRAPHIC | 1984690
| Complete submission text file | 0001193125-20-139879.txt |  | 2789674

Mailing Address 3 PRESTON COURT BEDFORD MA 01730
Business Address 3 PRESTON COURT BEDFORD MA 01730 781-430-8200
Stoke Therapeutics, Inc. (Filer) CIK: 0001623526 (see all company filings)

EIN.: 471144582 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38938 | Film No.: 20867142
SIC: 2834 Pharmaceutical Preparations